This groundbreaking new approach offers quality controlled, sequencing-ready NGS libraries in just a matter of hours, with minimal manual interaction and no sample loss.

NGS DreamPrep™ is a full walkaway solution that combines the Tecan Fluent® liquid handler and Infinite® plate reader, together with Celero™ DNA-Seq and Universal Plus mRNA-Seq library preparation kits – an optimized solution that brings significant improvements in speed, flexibility, accuracy and precision.

NGS experiments are time-consuming, expensive and generate vast quantities of data. This makes it particularly important that they are based on high-quality libraries that will yield valuable results. With NGS DreamPrep™, quantification, normalization and pooling of samples can all be achieved in significantly shorter timelines compared to other methods that use qPCR or capillary electrophoresis. Importantly, this is the first library preparation method to incorporate a QC step, which takes just five minutes, ensuring the generation of highly reproducible libraries that are ready to sequence.

Dr Klaus Lun, Executive Vice President Head of the Life Sciences Business Division, Tecan said: "Next-generation sequencing continues to revolutionize genomic research. Previously, the technique relied on libraries being quantified and normalized using methods that were time-consuming and subject to variability. NGS DreamPrep™enables users to easily transform samples into high quality, ready-to-use libraries."

NGS DreamPrep™brings together Tecan’s technical expertise in chemistry and protocol development together with unsurpassed engineering know-how of automation and detection instrumentation to ensure an optimized approach. All elements have been designed to work hand-in-hand and researchers benefit from having a single contact point plus dedicated Tecan application support.

The Tecan Group acquired US-based NuGEN Technologies, Inc., now named Tecan Genomics, in August 2018 to further expand Tecan's dedicated solutions offering into the new market segment of NGS reagents and kits, making the company the one-stop-shop for genomic sample preparation solutions. The Celero™DNA-Seq and Universal Plus mRNA-Seq kits are the first of the company’s NGS kits to be available for the NGS DreamPrep™.

Tecan is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2017, Tecan generated sales of CHF 548 million (USD 560 million; EUR 494 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).